View of Exploring the Cucurbitacin E (CuE) as an anti-lung cancer lead compound through molecular docking, ADMET, PASS prediction and drug likeness analysis

Return to Article Details Exploring the Cucurbitacin E (CuE) as an anti-lung cancer lead compound through molecular docking, ADMET, PASS prediction and drug likeness analysis Download Download PDF